Advanced Technology QA Center

先进技术质量保证中心

• 批准号: 8690240
• 负责人: Jeff M Michalski
• 金额: $ 128.78万
• 依托单位: WASHINGTON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-07-22 至 2014-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8690240
• 关键词: Architecture; Archives; Bioinformatics; Biology; Brachytherapy; Caring; Clinical Trials; Clinical Trials Cooperative Group; Clinical trial protocol document; Collaborations; Computer software; Conformal Radiotherapy; Credentialing; Custom; Data; Data Collection; Databases; Development; Electronic Health Record; Environment; Evaluation; Evolution; Future; Goals; Image; Information Management; Institution; Instruction; Intensity-Modulated Radiotherapy; Link; Maintenance; Malignant Neoplasms; Medical Informatics; Medicine; Methods; Modality; Online Systems; Organ; Outcome; Physics; Procedures; Process; Protocols documentation; Radiation Oncology; Radiation Therapy Oncology Group; Radiation therapy; Radiosurgery; Research Infrastructure; Research Personnel; Resources; Risk; Services; System; Technology; Testing; Therapy Clinical Trials; Training and Education; Vision; base; design; digital; electronic data; image guided radiation therapy; image guided therapy; improved; meetings; multidisciplinary; multimodality; novel; open source; programs; quality assurance; tool; treatment planning; tumor

DESCRIPTION (provided by applicant): Advanced Technology QA Center Our plan is to capitalize on the infrastructure and strengths of the nation's existing quality assurance (QA) programs that comprise our Advanced Technology QA Consortium (ATC), including the Image-Guided Therapy Center (ITC), Radiation Therapy Oncology Group (RTOG), Radiological Physics Center (RPC), and the Quality Assurance Review Center (QARC) to maintain/develop an advanced medical informatics infrastructure that provides an environment in which institutions can submit, and QA Centers can receive, share, and analyze volumetric multimodality imaging/treatment planning/verification (ITPV) digital data. Specifically, we will (1) maintain/manage (and make incremental improvements as required to) the current electronic data submission of advanced technology (3DCRT, IMRT, SBRT, and brachytherapy) protocol credentialing and case data, archival storage, and remote QA review process utilizing ATC Method-1 (now referred to as the QuASAR-1 (Quality Assurance Submission, Analysis, and Review-1) system); (2) develop novel web-based remote-review tools that will enhance the efficient and effective review of protocols utilizing advanced technologies. The design infrastructure of these tools will assist the development of future protocol processes such as image-guided radiation therapy (IGRT) and adaptive radiation therapy (ART). The proposed system is referred to as QuASAR-2 and will be modular in design to promote efficient tools and subsystems development that achieve compatibility with existing software standards, including the Cancer Bioinformatics Grid (caBIG) and DICOM RT, and maintain/develop archival ITPV, credentialing/QA databases that can be linked with the cooperative group's clinical outcomes database; (3) assist cooperative groups in the development and management of advanced technology clinical trials protocols including (a) tumor/target volume and organ at risk definitions; (b) credentialing requirements and evaluation criteria; (c) electronic data submission requirements/instructions; (d) QA review procedures; and (4) serve as an educational resource to the nation's clinical trial cooperative groups and participating institutions for support of advanced technology radiation therapy clinical trials. Our ATC QA consortium approach will help avoid duplication of service/developmental efforts and promote development of uniform credentialing/QA criteria for clinical trials throughout all Cooperative Groups.

描述（由申请人提供）： 先进技术QA中心 我们的计划是利用国家现有的质量保证（QA）计划的基础设施和优势，这些计划包括我们的先进技术QA联盟（ATC），包括图像引导治疗中心（ITC），放射治疗肿瘤组（RTOG），放射物理中心（RPC），和质量保证审查中心（QARC）维护/开发先进的医疗信息基础设施，提供一个环境，在该环境中，机构可以提交，QA中心可以接收，共享，并分析体积多模态成像/治疗计划/验证（ITPV）数字数据。具体而言，我们将（1）维护/管理（并根据需要逐步改进）目前电子数据提交的先进技术（3DCRT、IMRT、SBRT和近距离放射治疗）方案认证和病例数据、档案存储和使用ATC方法-1的远程QA审查过程（现称为QuASAR-1（质量保证提交、分析和审查-1）系统）;（2）开发新型网络远程审查工具，利用先进技术提高方案审查的效率和效力。这些工具的设计基础设施将有助于开发未来的协议过程，如图像引导放射治疗（IGRT）和自适应放射治疗（ART）。拟议的系统被称为QuASAR-2，将采用模块化设计，以促进有效的工具和子系统开发，实现与现有软件标准的兼容性，包括癌症生物信息学网格（caBIG）和DICOM RT，并维护/开发可与合作小组的临床结果数据库链接的ITPV、认证/质量保证数据库档案;（3）协助合作小组制定和管理先进技术的临床试验方案，包括（a）肿瘤/靶体积和危险器官的定义;（B）认证要求和评估标准;（c）电子数据提交要求/说明;（d）QA审查程序;以及（4）作为全国临床试验合作组和参与机构的教育资源，以支持先进技术的放射治疗临床试验。我们的ATC QA联盟方法将有助于避免服务/开发工作的重复，并促进在所有合作组中制定统一的临床试验认证/QA标准。

项目成果

Accuracy and sources of error of out-of field dose calculations by a commercial treatment planning system for intensity-modulated radiation therapy treatments.

• DOI: 10.1120/jacmp.v14i2.4139
• 发表时间: 2013-03-04
• 期刊: Journal of applied clinical medical physics
• 影响因子: 2.1
• 作者: Huang JY;Followill DS;Wang XA;Kry SF
• 通讯作者: Kry SF

Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios.

在 3 种具有挑战性的宫颈癌场景中调强放射治疗的临床靶区描绘的可变性。

• DOI: 10.1016/j.prro.2015.06.011
• 发表时间: 2015
• 期刊: Practical radiation oncology
• 影响因子: 3.3
• 作者: Lim,Karen;Erickson,Beth;Jürgenliemk-Schulz,InaM;Gaffney,David;Creutzberg,CarienL;Viswanathan,Akila;Portelance,Lorraine;Beriwal,Sushil;Wolfson,Aaron;Bosch,Walter;DeLosSantos,Jennifer;Yashar,Catheryn;Jhingran,Anuja;Varia,Mahes
• 通讯作者: Varia,Mahes

Development of a modified head and neck quality assurance phantom for use in stereotactic radiosurgery trials.

• DOI: 10.1120/jacmp.v14i4.4313
• 发表时间: 2013-07-08
• 期刊: Journal of applied clinical medical physics
• 影响因子: 2.1
• 作者: Faught AM;Kry SF;Luo D;Molineu A;Bellezza D;Gerber RL;Davidson SE;Bosch W;Drzymala RE;Galvin J;Timmerman R;Sheehan J;Gillin MT;Ibbott GS;Followill DS
• 通讯作者: Followill DS

Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer.

• DOI: 10.1016/j.ijrobp.2008.11.019
• 发表时间: 2009-03-15
• 期刊: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
• 影响因子: 7
• 作者: Xiao, Ying;Papiez, Lech;Paulus, Rebecca;Timmerman, Robert;Straube, William L.;Bosch, Wailter R.;Michalski, Jeff;Galvin, James M.
• 通讯作者: Galvin, James M.

In Reply to O'Sullivan et al.

回复奥沙利文等人。

• DOI: 10.1016/j.ijrobp.2012.05.038
• 发表时间: 2012
• 期刊: International journal of radiation oncology, biology, physics
• 作者: Wang,Dian;Bosch,Walter;Roberge,David;Finkelstein,StevenE;Petersen,Ivy;Haddock,Michael;Chen,Yen-LinE;Delaney,ThomasF;Saito,NaoyukiG;Kirsch,DavidG;Hitchcock,YingJ;Wolfson,AaronH
• 通讯作者: Wolfson,AaronH